Investors in Chengdu, China
Updated 16 Nov 2026
Venture funds
3 funds, by portfolio companies funded in the last 12 months| # | Fund | Sectors | Stages | Leads | Funded, 12 months |
|---|---|---|---|---|---|
| 1 | Chengdu High-tech Ceyuan Capital Chengdu High-tech Ceyuan Capital invests in Chinese technology companies such as Aerofugia and Kunteng Tech. Chengdu, China |
Health care, Biotech | Seed, Early stage venture, Late stage venture | 46% | 6 |
| 2 | Chengdu Science and Technology Venture Capital Chengdu Science and Technology Venture Capital is a venture firm with recent companies including Kunteng Tech, QL Biopharma and New Radiomedicine Technology. Chengdu, China |
Biotech, Health care | Early stage venture, Late stage venture | 36% | 3 |
| 3 | Si Chuan Venture Capital Si Chuan Venture Capital is a fund management and investment firm, with recent investments in Hyperway Pharm and Ghostcloud. Chengdu, China |
Health care, Biotech | Early stage venture | 29% | 3 |
Table 1. Investors in Chengdu, China: venture capital and micro VC funds ranked by companies whose most recent round closed in the last 12 months. Leads is the share of all recorded investments where the fund was lead investor. Source: FundingWatcher. Data as of 16 November 2026.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Investor | Type | Location | Phone | |
|---|---|---|---|---|
| Rising Investments | Venture capital firm | Chengdu, China | •••@cddxlz.com | 028-61••• |
| Yizhan Capital | Venture capital firm | Chengdu, China | •••@yizhancapital.com | 028 87••• |
| Yunshi Capital | Private equity firm | Chengdu, China | •••@yunzb.cn | 028-83••• |
| Chengdu Technology Transfer Group | Venture capital firm | Chengdu, China | •••@cttg.com.cn | 028-62••• |
| MingFeng Capital | Private equity firm | Chengdu, China | •••@163.com | 028-86••• |
| ULTIMA | Private equity firm | Chengdu, China | •••@ultimacap.com | 028-65••• |
| Huaxi Jinzhi Investment | Private equity firm | Chengdu, China | •••@hx168.com.cn | 028-86••• |
| Born Capital | Fund of funds | Chengdu, China | •••@bornpe.com |
8 rows of the CSV in 5 of its 15 columns, email and phone masked.
- 9 of the 33 investors in Chengdu, China have a published email address, 13 a phone number and 25 a website.
- Chengdu Science and Technology Venture Capital has the most recorded investments, 67, 24 of them as lead investor.
- 6 of them are investors in at least one company that closed its most recent round in the last 12 months.
- Chengdu High-tech Ceyuan Capital is an investor in 6 of those companies, more than any other investor on this list.
- The newest round among their portfolio companies is Hyperway Pharm's $14.9M Series B on 15 October 2026.
- Software is the most common sector across their 49 portfolio companies (41%).
- Early stage venture is the most common investment stage, recorded for 23 of them (70%).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Investors in Chengdu, China
25 of 33, most investments first| # | Investor | Type | Location | Invests in | Latest portfolio companies | Funded, 12 months | Investments | Lead | Exits | Phone | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Chengdu Science and Technology Venture Capital | Venture capital firm | Chengdu, China | Biotech, Health care | Kunteng Tech, QL Biopharma, New Radiomedicine Technology | 3 | 67 | 24 | 1 | |||
| 2 | Chengdu High-tech Ceyuan Capital | Venture capital firm | Chengdu, China | Health care, Biotech | Kunteng Tech, Hyperway Pharm, Chuangzhi Lianheng | 6 | 39 | 18 | 2 | (028) ••• | ||
| 3 | Rising Investments | Venture capital firm | Chengdu, China | Hardware, Energy | Aerospace Kate, Ultron Photonics, SimChip Technology | 34 | 12 | 2 | •••@cddxlz.com | 028-61••• | ||
| 4 | Beyond Capital | Private equity firm, Venture capital firm | Chengdu, China | Hardware | AOSSCI | 1 | 30 | 5 | 1 | 028-85••• | In the CSV | |
| 5 | Si Chuan Venture Capital | Venture capital firm | Chengdu, China | Health care, Biotech | Hyperway Pharm, Ghostcloud, Zenitar | 3 | 24 | 7 | 0 | 86-123••• | ||
| 6 | CDHTI Venture Capital | Venture capital firm | Chengdu, China | Hardware, Health care | First Technology, Vantron, Maimai | 17 | 0 | 6 | In the CSV | |||
| 7 | Guanghua Wutong Fund | Private equity firm | Chengdu, China | 14 | 1 | 0 | ||||||
| 8 | Yizhan Capital | Venture capital firm | Chengdu, China | Hardware | Chengdu Maike, Taco Optoelectronics, Lixin Huigan | 14 | 1 | 0 | •••@yizhancapital.com | 028 87••• | ||
| 9 | Yunshi Capital | Private equity firm | Chengdu, China | Hardware, Artificial intelligence | IceWhale Technology, Pinzhou Technology, Meilin | 11 | 4 | 1 | •••@yunzb.cn | 028-83••• | ||
| 10 | Chengdu Hi-tech Investment Group | Chengdu, China | 10 | 2 | 1 | +86-28••• | In the CSV | |||||
| 11 | The Force Capital | Venture capital firm | Chengdu, China | Software | Aoyi Network Technology | 9 | 6 | 0 | 028-85••• | |||
| 12 | Chengdu Technology Transfer Group | Venture capital firm | Chengdu, China | 9 | 4 | 1 | •••@cttg.com.cn | 028-62••• | ||||
| 13 | MingFeng Capital | Private equity firm | Chengdu, China | 7 | 3 | 0 | •••@163.com | 028-86••• | ||||
| 14 | Chuangshi Ziben | Venture capital firm | Chengdu, China | Fintech, Energy | SAI.TECH, Lian Tianxia | 7 | 1 | 2 | ||||
| 15 | ULTIMA | Private equity firm | Chengdu, China | Hardware, Health care | Maimai, VRDREAMS | 7 | 0 | 0 | •••@ultimacap.com | 028-65••• | In the CSV | |
| 16 | Huaxi Jinzhi Investment | Private equity firm | Chengdu, China | 6 | 3 | 0 | •••@hx168.com.cn | 028-86••• | ||||
| 17 | Shenzhen Qianhai Beizeng Asset Management | Private equity firm | Chengdu, China | 6 | 3 | 0 | ||||||
| 18 | Chengdu Jiaozi Financial Holding | Government investment office | Chengdu, China | 5 | 1 | 0 | ||||||
| 19 | SECCO Investment | Venture capital firm | Chengdu, China | Hardware | Giant Micro Integrated Circuit, Yunchuang Zhixing | 3 | 3 | 0 | ||||
| 20 | Born Capital | Fund of funds, Private equity firm | Chengdu, China | Fintech | Qianke Finance | 3 | 1 | 0 | •••@bornpe.com | |||
| 21 | Chengdu Industrial Investment | Corporate venture arm, Venture capital firm | Chengdu, China | 3 | 0 | 0 | ||||||
| 22 | China Economic Capital | Private equity firm | Chengdu, China | 3 | 0 | 0 | ||||||
| 23 | Sichuan Provincial Investment Group | Venture capital firm | Chengdu, China | 2 | 1 | 0 | In the CSV | |||||
| 24 | Qianhai Beizeng | Private equity firm | Chengdu, China | 1 | 0 | 0 | ||||||
| 25 | Winpower | Private equity firm, Venture capital firm | Chengdu, China | 1 | 0 | 0 | •••@winpow.com | 028-85••• |
Table 2. Investors in Chengdu, China: the first 25 by recorded investments with a website and a location. Email and phone are masked here and complete in the CSV. Source: FundingWatcher. Data as of 16 November 2026. Base: 33.
Most active in the last 12 months
By portfolio companies funded| # | Investor | Location | Funded, 12 months | Portfolio | Latest |
|---|---|---|---|---|---|
| 1 | Chengdu High-tech Ceyuan Capital | Chengdu, China | 6 | 6 | Kunteng Tech, Hyperway Pharm, Chuangzhi Lianheng |
| 2 | Chengdu Science and Technology Venture Capital | Chengdu, China | 3 | 6 | Kunteng Tech, QL Biopharma, New Radiomedicine Technology |
| 3 | Si Chuan Venture Capital | Chengdu, China | 3 | 7 | Hyperway Pharm, Ghostcloud, Zenitar |
| 4 | Guosheng Capital | Chengdu, China | 2 | 2 | Lingtai Krypton Biotechnology, Novamab |
| 5 | Beyond Capital | Chengdu, China | 1 | 2 | AOSSCI |
| 6 | Beite Fund | Chengdu, China | 1 | 1 | Paiz Interconnect |
Table 3. Investors in Chengdu, China: investors in the most companies whose most recent round falls in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Latest rounds in their portfolios
Newest first| Company | What they do | Sector | Location | Last round | Amount | Date | Total raised | Investors on this list | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| Hyperway Pharm | Hyperway Pharm conducts pharmaceutical research, development, and production. | Health care | Chengdu, China | Series B | $14.9M | 2026-10-15 | $56.8M | Chengdu High-tech Ceyuan Capital, Si Chuan Venture Capital | 51 to 100 | 2019 |
| QL Biopharma | QL Biopharma develops recombinant protein drugs to treat chronic metabolic diseases. | Biotech | Beijing, China | Series C | $44.7M | 2026-09-14 | $173.7M | Chengdu Science and Technology Venture Capital | 101 to 250 | 2018 |
| Lingtai Krypton Biotechnology | Lingtai Krypton Biotechnology develops lncRNA drugs to treat human diseases. | Biotech | Shuangliu, China | Series A | $13.7M | 2026-06-26 | $13.7M | Guosheng Capital | 11 to 50 | 2021 |
| Yuntian Imagination | Yuntian Imagination provides interactive video cloud services with ultra-high-definition quality and low-latency streaming. | Software | Shenzhen, China | Series E | $148.0M | 2026-06-17 | $248.0M | Chengdu High-tech Ceyuan Capital | 101 to 250 | 2020 |
| Ghostcloud | Ghostcloud is a Kubernetes Certified Service Provider. | Software | Chengdu, China | Series B | $14.7M | 2026-05-08 | $17.7M | Si Chuan Venture Capital | 51 to 100 | 2015 |
| Novamab | Novamab researches and develops new nanobodies. | Biotech | Shanghai, China | Series B | $43.9M | 2026-04-24 | $97.8M | Guosheng Capital | 51 to 100 | 2017 |
| New Radiomedicine Technology | New Radiomedicine Technology supplies medical isotopes in China. | Biotech | Chengdu, China | Series E | $145.4M | 2026-04-03 | $330.6M | Chengdu Science and Technology Venture Capital | 101 to 250 | 2016 |
| Zenitar | Zenitar conducts drug research and biomedical technology industrialization. | Biotech | Chengdu, China | Series C | $86.0M | 2026-01-12 | $155.7M | Chengdu High-tech Ceyuan Capital, Si Chuan Venture Capital | 51 to 100 | 2019 |
Table 4. Investors in Chengdu, China: the 8 most recent rounds of companies they back. Source: FundingWatcher. Data as of 16 November 2026.
Portfolio sectors
| Portfolio sectors | Companies | Share |
|---|---|---|
| Software | 20 | 41% |
| Hardware | 16 | 33% |
| Health care | 10 | 20% |
| Biotech | 6 | 12% |
| Fintech | 4 | 8% |
| Energy | 4 | 8% |
| Artificial intelligence | 3 | 6% |
| Education | 2 | 4% |
Table 5. Investors in Chengdu, China: portfolio companies by sector. Source: FundingWatcher. Data as of 16 November 2026.
Investment stages
| Investment stages | Investors | Share |
|---|---|---|
| Early stage investors | 23 | 70% |
| Seed investors | 9 | 27% |
| Private equity investors | 8 | 24% |
| Venture investors | 5 | 15% |
| Late stage investors | 4 | 12% |
| Debt investors | 1 | 3% |
| Post IPO investors | 1 | 3% |
Table 6. Investors in Chengdu, China by stage they invest at. Source: FundingWatcher. Data as of 16 November 2026.
Founded
| Founded | Investors | Share |
|---|---|---|
| 2020s | 4 | 17% |
| 2010s | 13 | 54% |
| 2000s | 5 | 21% |
| 1990s | 1 | 4% |
| 1980s | 1 | 4% |
Table 7. Investors in Chengdu, China by founding decade. Source: FundingWatcher. Data as of 16 November 2026.
Method
- An investor is on this list when its headquarters is in Chengdu, China. On 16 November 2026 that is 33 investors.
- 9 rows carry an email address and 13 a phone number from the investor file. Investments, lead investments and exits are the counts the source records.
- The table prints the first 25 rows by recorded investments that carry a website and a location, with email and phone masked. The CSV carries all 33 rows: 8 have no website and 0 no location.
Sources, fields and exclusions of both files: Method.
Questions
- How many investors in Chengdu, China are on the list?
- 33, in the file dated 16 November 2026. 6 of them invested in a company whose most recent round falls in the last 12 months.
- How many have an email address?
- 9 of the 33 carry an email address in the download and 13 a phone number.
- What does the CSV contain?
- One row per investor, 15 columns: name, types, stages, city, region, country, founded, website, linkedin, investments, funded_last_12m, exits, lead_investments, email, phone.
- How much does the list cost?
- $29 one-time for all 33 rows, no account. Every investor and every startup, two files, cost $99. With partner contacts, up to 2 per firm compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV with 33 rows, 9 firm email addresses and 13 phone numbers, on the page after payment and by mail. The emails are the address a firm publishes: 2 of the 9 are inboxes such as info@ or contact@. No partner names.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.